pharmaceutical investing Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304
Ni-Co Energy Launches Approximately 7,500-Metre Drill Program at the Kremer Project; First Hole Targets Kremer-2
